We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Abbott Introduces GLP Systems Track Laboratory Automation Solution

By LabMedica International staff writers
Posted on 22 May 2023

Abbott (Lake Forest, IL, USA) is participating in EuroMedLab-WorldLab 2023 where it is introducing GLP Systems, an innovative total laboratory automation (TLA) solution, offering proven technology with more flexibility and options to meet high volume needs. More...

Clinical labs are constantly on the lookout for solutions that can help them process an increasing number of sample tubes more efficiently, while simultaneously reducing costs and maintenance of their systems. A significant objective is to facilitate connectivity with a diverse range of instruments, which would help reduce both complexity and cost, and most importantly, simplify the decision-making process regarding automation. The GLP TLA system, which employs an automated sample delivery track system, handles an impressive 900 samples per hour end-to-end. This automation significantly cuts down turnaround time, positively impacting patient care, especially in critical care units. The system also includes a feature that limits direct contact with patients' blood samples, thus safeguarding the workers. It enhances efficiency through consistent sample management, thereby ensuring a more reliable and speedier laboratory service.

The GLP TLA system can markedly boost the efficacy of laboratory testing. A standout feature of this system is its multi-floor transport capability, which eliminates the boundaries between various departments and floors, thereby expediting the availability of test results for doctors. The GLP TLA system mitigates the risks associated with implementing a long-term solution, thanks to its innovative track design. Labs now have the flexibility to modify their track to accommodate future changes and can optimize floor space by evolving their labs from a 2D to a 3D setup. The system also alleviates the common difficulties associated with adopting a new automation system by minimizing the time needed for track implementation and offering more efficient service and training. The GLP TLA system allows labs to concentrate on crucial tasks by maximizing uptime with infinite redundancy, streamlining workflow, and reducing turnaround time.

Related Links:
Abbott 


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.